Reduced biological effect of e-cigarette aerosol compared to cigarette smoke evaluated in vitro using normalized nicotine dose and RNA-seq-based toxicogenomics

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Haswell, Linsey E ^a   Baxter, Andrew ^a   Banerjee, Anisha ^a   Verrastro, Ivan ^a   Mushonganono, Jessica ^a   Adamson, Jason ^a   Thorne, David ^a   Gaça, Marianna ^a   Minet, Emmanuel ^a  

^a BRITISH AMERICAN TOBACCO   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; TRANSCRIPTOME;

CELL CULTURE; CIGARETTE SMOKING; COMPARATIVE STUDY; DRUG EFFECT; ELECTRONIC CIGARETTE; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; RESPIRATORY MUCOSA; VAPING;

CELLS, CULTURED; CIGARETTE SMOKING; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; RESPIRATORY MUCOSA; TRANSCRIPTOME; VAPING;

EID: 85018795480     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-00852-y     Document Type: Article

References (56)

1. Farsalinos, K. E., Romagna, G., Tsiapras, D., Kyrzopoulos, S. & Voudris, V. Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19,000 consumers. Int. J. Environ. Res. Public Health 11, 4356-4373, doi:10.3390/ijerph110404356 (2014).
2. Hajek, P., Etter, J. F., Benowitz, N., Eissenberg, T. & McRobbie, H. Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction 109, 1801-1810, doi:10.1111/add.2014.109.issue-11 (2014).
3. McNeill, A. et al. E-cigarettes: an evidence update (Public Health England). https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/457102/Ecigarettes-An-evidence-update-A-report-commissioned-by-Public-Health-England-FINAL.pdf. Date of access: 6-10-2016 (2015).
4. Amos, A. et al. Nicotine without smoke: Tobacco harm reduction. https://www.rcplondon.ac.uk/news/promote-e-cigarettes-widelysubstitute-smoking-says-new-rcp-report. Date of access: 6-10-2016 (2016).
5. Iskandar, A. R. et al. 3-D nasal cultures: Systems toxicological assessment of a candidate modified-risk tobacco product. ALTEX. 34, 23-48, doi:10.14573/altex.1605041 (2016).
6. Shen, Y., Wolkowicz, M. J., Kotova, T., Fan, L. & Timko, M. P. Transcriptome sequencing reveals e-cigarette vapor and mainstreamsmoke from tobacco cigarettes activate different gene expression profiles in human bronchial epithelial cells. Sci. Rep 6, 23984, doi:10.1038/srep23984 (2016).
7. Krewski, D. et al. Toxicity testing in the 21st century: a vision and a strategy. J. Toxicol. Environ. Health. B. Crit. Rev. 13, 51-138, doi :10.1080/10937404.2010.483176 (2010).
8. Birnbaum, L. S., Burke, T. A. & Jones, J. J. Informing 21st-Century Risk Assessments with 21st-Century Science. Environ. Health Perspect. 124, A60-A63, doi:10.1289/ehp.1511135 (2016).
9. Moffat, I. et al. Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water. Crit. Rev. Toxicol. 45, 1-43, doi:10.3109/10408444.2014.973934 (2015).
10. Kogel, U. et al. Biological impact of cigarette smoke compared to an aerosol produced from a prototypic modified risk tobacco product on normal human bronchial epithelial cells. Toxicol. In Vitro. 29, 2102-2115, doi:10.1016/j.tiv.2015.08.004 (2015).
11. Wang, Z., Gerstein, M. & Snyder, M. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10, 57-63, doi:10.1038/nrg2484 (2009).
12. Scheffler, S. et al. Evaluation of E-cigarette liquid vapor and mainstream cigarette smoke after direct exposure of primary human bronchial epithelial cells. Int. J. Environ. Res. Public. Health. 12, 3915-3925, doi:10.3390/ijerph120403915 (2015).
13. Yu, V. et al. Electronic cigarettes induce DNA strand breaks and cell death independently of nicotine in cell lines. Oral. Oncol. 52, 58-65, doi:10.1016/j.oraloncology.2015.10.018 (2016).
14. Thorne, D. & Adamson, J. A review of in vitro cigarette smoke exposure systems. Exp. Toxicol. Pathol 65, 1183-1193, doi:10.1016/j. etp.2013.06.001 (2013).
15. Adamson, J., Thorne, D., McAughey, J., Dillon, D. & Meredith, C. Quantification of cigarette smoke particle deposition in vitro using a triplicate quartz crystal microbalance exposure chamber. Biomed. Res. Int. 2013, 1-9, doi:10.1186/s13065-016-0221-9 (2013).
16. Thorne, D. et al. Characterisation of a Vitrocell(R) VC 10 in vitro smoke exposure system using dose tools and biological analysis. Chem. Cent. J. 7, 146, doi:10.1186/1752-153X-7-146 (2013).
17. Nother, K., Ashley, M. & Clayton, P. Influence of Type and Amount of Carbon in Cigarette Filters on Smokers' Mouth Level Exposure to "Tar", Nicotine, 1,3-Butadiene, Benzene, Toluene, Isoprene, and Acrylonitrile. Beiträge zur Tabakforschung International 27, 40-53, doi:10.1515/cttr-2016-0007 (2016).
18. Lee, Y. H., Gawron, M. & Goniewicz, M. L. Changes in puffing behavior among smokers who switched from tobacco to electronic cigarettes. Addict. Behav. 48, 1-4, doi:10.1016/j.addbeh.2015.04.003 (2015).
19. Lopez, A. A. et al. Effects of Electronic Cigarette Liquid Nicotine Concentration on Plasma Nicotine and Puff Topography in Tobacco Cigarette Smokers: A Preliminary Report. Nicotine. Tob. Res. 18, 720-723, doi:10.1093/ntr/ntv182 (2016).
20. WHO SOP: Standard operating procedure for intense smoking regime of cigarettes. www.who.int/iris/bitstream/10665/75261/1/9789241503891-eng.pdf. Date of access: 17-08-2016 (2012).
21. Stevens, R. CORESTA Electronic Cigarette Task Force. https://www.coresta.org/sites/default/files/pages/CORESTA-ECIG-TF-FDA-Ecig-Wrkshp-20141210-11.pdf. Date of access 7-08-2016 (2014).
22. Lin, H. et al. Air-liquid interface (ALI) culture of human bronchial epithelial cell monolayers as an in vitro model for airway drug transport studies. J. Pharm. Sci. 96, 341-350, doi:10.1002/jps.20803 (2007).
23. Turner, J. et al. Goblet cells are derived from a FOXJ1-expressing progenitor in a human airway epithelium. Am. J. Respir. Cell Mol. Biol. 44, 276-284, doi:10.1165/rcmb.2009-0304OC (2011).
24. Banerjee, A. et al. Differential Gene Expression Using RNA Sequencing Profiling in a Reconstituted Airway Epithelium Exposed to Conventional Cigarette Smoke or Electronic Cigarette Aerosols. App. In Vitro Tox. 3, 84-98, doi:10.1089/AIVT.2016.0024 (2017).
25. Azzopardi, D. et al. Electronic cigarette aerosol induces significantly less cytotoxicity than tobacco smoke. Toxicol. Mech. Methods 26, 477-491, doi:10.1080/15376516.2016.1217112 (2016).
26. Husari, A. et al. Acute Exposure to Electronic and Combustible Cigarette Aerosols: Effects in an Animal Model and in Human Alveolar Cells. Nicotine. Tob. Res. 18, 613-619, doi:10.1093/ntr/ntv169 (2016).
27. Teasdale, J. E., Newby, A. C., Timpson, N. J., Munafo, M. R. & White, S. J. Cigarette smoke but not electronic cigarette aerosol activates a stress response in human coronary artery endothelial cells in culture. Drug Alcohol. Depend. 163, 256-260, doi:10.1016/j. drugalcdep.2016.04.020 (2016).
28. Adamson, J. et al. Application of dosimetry tools for the assessment of e-cigarette aerosol and cigarette smoke generated on two different in vitro systems. Chem.Central J. 10, doi:10.1186/s13065-016-0221-9 (2016).
29. Yuteri, C., Adamson, J. & McAughey, J. Dose equivalence : human cigarette smoking versus in vitro at the air-liquid interface. European Aerosol Conference (2016).
30. Margham, J. et al. Chemical Composition of Aerosol from an E-Cigarette: A Quantitative Comparison with Cigarette Smoke. Chem. Res. Toxicol (2016).
31. Antherieu, S. et al. Comparison of cellular and transcriptomic effects between electronic cigarette vapor and cigarette smoke in human bronchial epithelial cells. Toxicol. In Vitro doi:10.1016/j.tiv.2016.015 (2017).
32. Adcock, I. M., Caramori, G. & Barnes, P. J. Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration. 81, 265-284, doi:10.1159/000324601 (2011).
33. Barnes, P. J. et al. Chronic obstructive pulmonary disease. Nat. Rev. Dis. Primers 1, 15076, doi:10.1038/nrdp.2015.76 (2015).
34. Sriram, K. B. et al. Screening for activating EGFR mutations in surgically resected nonsmall cell lung cancer. Eur. Respir. J. 38, 903-910, doi:10.1183/09031936.00190110 (2011).
35. Kramer, A., Green, J., Pollard, J. Jr. & Tugendreich, S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 30, 523-530, doi:10.1093/bioinformatics/btt703 (2014).
36. Iskandar, A. R. et al. A systems toxicology approach for comparative assessment: Biological impact of an aerosol from a candidate modified-risk tobacco product and cigarette smoke on human organotypic bronchial epithelial cultures. Toxicol. In Vitro 39, 29-51, doi:10.1016/j.tiv.2016.11.009 (2017).
37. Beane, J. et al. Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq. Cancer Prev. Res. (Phila) 4, 803-817, doi:10.1158/1940-6207.CAPR-11-0212 (2011).
38. Chari, R. et al. Effect of active smoking on the human bronchial epithelium transcriptome. BMC. Genomics. 8, 297, doi:10.1186/1471-2164-8-297 (2007).
39. Hackett, N. R. et al. RNA-Seq quantification of the human small airway epithelium transcriptome. BMC. Genomics. 13, 82, doi:10.1186/1471-2164-13-82 (2012).
40. Mathis, C. et al. Human bronchial epithelial cells exposed in vitro to cigarette smoke at the air-liquid interface resemble bronchial epithelium from human smokers. Am. J. Physiol. Lung Cell Mol. Physiol. 304, L489-L503, doi:10.1152/ajplung.00181.2012 (2013).
41. UK Human Tissue Act 2004. https://www.hta.gov.uk/policies/list-materials-considered-be-%E2%80%98relevantmaterial% E2%80%99-under-human-tissue-Act-2004. Date of access 28-02-2017 (2009).
42. ISO 3402:1999. Tobacco and tobacco products-Atmosphere for conditioning and testing. International Organization for Standardization. https://www.iso.org/obp/ui/#iso:std:28324:en. Date of access: 17-08-2016 (1999).
43. Department of Health (Canada), Official Method T-115: Determination of "Tar", nicotine and carbon monoxide in mainstream tobacco smoke. (Health Canada 1999).
44. Onoue, S., Yamamoto, N., Seto, Y. & Yamada, S. Pharmacokinetic study of nicotine and its metabolite cotinine to clarify possible association between smoking and voiding dysfunction in rats using UPLC/ESI-MS. Drug Metab. Pharmacokinet. 26, 416-422, doi:10.2133/dmpk.DMPK-11-RG-019 (2011).
45. Jin, M. et al. A LC-MS/MS method for concurrent determination of nicotine metabolites and role of CYP2A6 in nicotine metabolism in U937 macrophages: implications in oxidative stress in HIV + smokers. J. Neuroimmune. Pharmacol 7, 289-299, doi:10.1007/s11481-011-9283-6 (2012).
46. Sisson, J. H., Stoner, J. A., Ammons, B. A. & Wyatt, T. A. All-digital image capture and whole-field analysis of ciliary beat frequency. J. Microsc. 211, 103-111, doi:10.1046/j.1365-2818.2003.01209.x (2003).
47. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 29, 15-21 (2013).
48. Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511-515, doi:10.1038/nbt.1621 (2010).
49. Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome. Biol. 15, R29, doi:10.1186/gb-2014-15-2-r29 (2014).
50. Law, C. W., Alhamdoosh, M., Su, S., Smyth, G. K. & Ritchie, M. E. RNA-seq analysis is easy as 1-2-3 with limma, Glimma and edgeR. F1000Res 5, 1408, doi:10.12688/f1000research.9005.2 (2016).
51. Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, R25, doi:10.1186/gb-2010-11-3-r25 (2010).
52. Kauffmann, A. & Huber, W. Microarray data quality control improves the detection of differentially expressed genes. Genomics. 95, 138-142, doi:10.1016/j.ygeno.2010.01.003 (2010).
53. Kozera, B. & Rapacz, M. Reference genes in real-time PCR. J. Appl. Genet 54, 391-406, doi:10.1007/s13353-013-0173-x (2013).
54. Hochberg, Y. & Benjamini, Y. More powerful procedures for multiple significance testing. Stat. Med. 9, 811-818, doi:10.1002/(ISSN)1097-0258 (1990).
55. Qiagen. Pathway-Focused Arrays. http://www.sabiosciences.com/ArrayList.php. Date of access: 5-7-2013 (2012).
56. Wencke, W. GOplot 1.0.2. https://cran.r-project.org/web/packages/GOplot/vignettes/GOplot-vignette.html. Date of access: 6-10-2016 (2016).